Cardiac metabolomics stands at the forefront of scientific inquiry, delving into the intricate world of small molecules governing the metabolic intricacies within the heart. This emerging discipline employs advanced analytical techniques to comprehensively explore the dynamic landscape of metabolites, unraveling the complex web of metabolic pathways in the cardiovascular system. By deciphering the nuanced changes in metabolite profiles, researchers aim to uncover the molecular underpinnings of cardiac health and disease. This profound understanding has the potential to revolutionize diagnostic approaches and therapeutic strategies, offering a unique perspective on personalized medicine in the realm of cardiovascular care. In the realm of cardiac metabolomics, scientists strive to identify distinctive metabolic signatures linked to various cardiac conditions, paving the way for tailored interventions and enhancing our ability to precisely detect, monitor, and treat cardiovascular diseases.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt